Home » Topics » Regulatory

Regulatory
RSS

FDA clears new indication for Prevacid

April 17, 1998

Cosopt receives marketing approval from FDA

April 16, 1998

Antiviral drugs advisory committee will discuss Intron A/Rebetol NDA

April 15, 1998

FDA approves fifth indication for Neupogen

April 14, 1998

Orphan Medical receives approval to market Sucraid in U.S.

April 14, 1998

Expanded indication approved for Proscar

April 8, 1998

FDA approves Actonel for Paget's disease

April 3, 1998

FDA clears pravastatin for stroke prevention

March 31, 1998

FDA approves Viagra; first oral treatment for ED on the way to market

March 30, 1998

FDA advisory committee recommends Taxol for new indications

March 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...